Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy, safety, and pharmacokinetics of LP-005 injection in individuals with paroxysmal nocturnal hemoglobinuria; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• LP-005 Injection

Snippet

Sponsor: Longbio Pharma | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | Status: NOT_YET_RECRUITING